Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF- dilatation in congestive heart failure

Cardiovascular Research

Volumn 43, Issue 1, 1999, Pages 200-209

  Malmsjö, Malin ^a   Bergdahl, Anders ^a   Zhao, Xiao He ^b   Sun, Xiang Ying ^b   Hedner, Thomas ^b   Edvinsson, Lars ^a   Erlinge, David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adenosine; Endothelial function; Heart failure; Nitric oxide; Regional bloodflow

Indexed keywords

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; HEART RECEPTOR; NITRIC OXIDE; NORADRENALIN; URIDINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART INFARCTION SIZE; HEART LEFT VENTRICLE WALL; HEART MUSCLE PERFUSION; MALE; MEAN ARTERIAL PRESSURE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; VASODILATATION;

ACETYLCHOLINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; APAMIN; BIOLOGICAL FACTORS; CHARYBDOTOXIN; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEART FAILURE, CONGESTIVE; INDOMETHACIN; LINEAR MODELS; MALE; NITRIC OXIDE SYNTHASE; NITROARGININE; NUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; URIDINE TRIPHOSPHATE; VASODILATOR AGENTS;

EID: 0033063347     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00062-0     Document Type: Article

References (43)

1. Holton F.A., Holton P. The possibility that ATP is a transmitter at sensory nerve endings. J Physiol (London). 119:1953;50P-51P.
2. Dzau V.J., Colucci W.S., Hollenberger N.K., Williams G.H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 63:1981;645-651.
3. Chen G., Suzuki H., Weston A.H. Acetylcholine releases endothelial-derived hyperpolarising factor and EDRF from rat blood vessels. Br J Pharmacol. 95:1988;1165-1174.
4. Burnstock G. Vascular control by purines with emphasis on the coronary system. Eur Heart J. 10:(suppl F):1989;15-21.
5. Malmsjö M., Edvinsson L., Erlinge D. P2U-receptor mediated endothelium-dependent but nitric oxide independent vascular relaxation. Br J Pharmacol. 123:(4):1998;719-729.
6. Malmsjö M., Erlinge D., Högestätt E., Zygmunt P. Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium derived hyperpolarising factor. Eur J Pharmacol. 364:1999;169-173.
7. Chidsey C.A., Braunwald E., Morrow A.G. Catecholamine excretion and cardiac stores of norephinephrine in congestive heart failure. Am J Med. 39:1965;442-451.
8. Edvinsson L., Ekman R., Hedner P., Valdemarsson S. Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres. Eur J Clin Invest. 20:1990;85-89.
9. McMurray J.J., Ray S.G., Abdullah I., Dargie H.J., Morton J.J. Plasma endothelin in chronic heart failure. Circulation. 85:1992;1374-1379.
10. Rodeheffer R.J., Lerman A., Heublein D.M., Burnett J.C. Increased levels of endothelin in congestive heart failure. Mayo Clin Proc. 67:1992;719-724.
11. Gunther A., Riegger J., Liebau G., Kochsiek K. Antidiuretic hormone in congestive heart failure. Am J Med. 72:1982;49-52.
12. Goldsmith S.R., Francis G.S. Jr., Cowley A.W., Levine T.B., Cohn J.N. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1:1983;1385-1390.
13. Holtz J., Förstermann U., Pohl U., Giesler M., Bassenge E. Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol. 6:1984;1161.
14. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 266:1994;E829-E839.
15. Pohl U., Holz J., Busse R., Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 8:1986;37.
16. Rubanyi G.M., Romero J.C., Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 231:1986;H405.
17. Vallance P Collier J Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet. 1989;997.
18. Drexler H.D., Hornig B. Importance of endothelial function in chronic heart failure. J Card Pharmacol. 27:1996;S9-S12.
19. Katz S.D., Schwartz M., Yuen J., LeJemtel T.H. Impaired acethylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation. 88:1993;55-61.
20. Lindsay D.C., Jiang C., Brunotte F., Adamopoulos S., Coats A.J.S., Rajagopalan B., Poole-Wilson P.A., Collins P. Impairment of endothelium dependent responses in a rat model of chronic heart failure: effects of an exercise training protocol. Cardiovasc Res. 26:1992;694-697.
21. Vargas F., Osuna A., Fernandez-Rivas A. Vascular reactivity and flow-pressure curve in isolated kidneys from rats with N-nitro-L-arginine methyl ester-induced hypertension. J Hypertens. 14:1996;373-379.
22. Makino A., Kamata K. Eleveted plasma endothelin-1 in streptozotocin-induced diabetic rats and responsiveness of the mesenteric arterial bed to endothelin-1. Br J Pharmacol. 123:1998;1065-1072.
23. Brandes R.P., Behra A., Lebherz C., Boger R.H., Bode-Boger S.M., Phivthong-Ngam L., Mugge A. N(G)-nitro-L-arginine- and indomethacin-resistant endothelium-dependent relaxation in the rabbit renal artery: effect of hypercholesterolemia. Atherosclerosis. 135:1997;49-55.
24. Burnstock G. Dual control of local blood flow by purines. Biological actions of extracellular ATP. Ann NY Acad Sci. 603:1990;31-45.
25. Valdemarsson S., Bergdahl A., Edvinsson L. Relationships between plasma levels of catecholamines and neuropeptides and the survival times in patients with congestive heart failure. J Int Med. 235:1994;595-601.
26. Bergdahl A., Valdemarsson S., Pantev E., Ottosson A., Feng Q.-P., Sun X.-Y., Hedner T., Edvinsson L. Modulation of vascular contractile response to α1- and α2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure. Acta Physiol Scand. 154:1995;429-437.
27. Funaya H., Kitakaze M., Node K., Minamino T., Komamura K., Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation. 95:1997;1363-1365.
28. Gordon J.L. Extracellular ATP: Effects, sources and fate. Biochem J. 233:1986;309-319.
29. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., Fletcher P.J., Spadaro J., Kloner R.A., Braunwald E. Myocardial infarction size and ventricular function in rats. Circ Res. 44:1979;503-512.
30. Högestätt E., Andersson K.-E., Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 117:1983;49-61.
31. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 81:1990;1161-1172.
32. Tikkanen T., Tikkanen I., Fyhrquist F. Elevated plasma atrial natriuretic peptid in rats with myocardial infarcts. Life Sci. 40:1987;659-663.
33. Valdemarsson S., Bergdahl A., Edvinsson L. Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure. J Intern Med. 235:1994;595-601.
34. Pfeffer M.A., Pfeffer J.M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with catopril. Circulation. 72:1985;406-412.
35. Taylor S.G., Weston A.H. Endothelium-derived hyperpolarising factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci. 9:1988;272-274.
36. Campbell W.B., Gebremedhin D., Pratt F.P., Harder D.R. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor. Circ Res. 78:1996;415-423.
37. Corriu C., Feletou M., Canet E., Vanhoutte P.M. Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol. 119:1996;959-964.
38. Zygmunt P.M., Högestätt E.D. Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br J Pharmacol. 117:1996;1600-1606.
39. Chataigneau T., Feletou M., Thollon C., Villeneuve N., Vilaine J.P., Duhault J., Vanhoutte P.M. Cannabinoid CB1 receptor and endothelium-dependent hyperpolarization in guinea-pig carotid, rat mesenteric and porcine coronary arteries. Br J Pharmacol. 123:1998;968-974.
40. Zygmunt P.M., Plane F., Paulsson M., Garland C.J., Högestätt E.D. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Br J Pharmacol. 124:1998;992-1000.
41. Zygmunt P.M., Grundemar L., Högstätt E.D. Endothelium-dependent relaxation resistant to Nω-nitro-L-arginine in the rat hepatic artery and aorta. Acta Physiol Scand. 152:1994;107-114.
42. Mantell L., Amerini S., Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol. 25:1995;595-602.
43. Bauersachs J., Popp R., Hecker M., Sauer E., Flemming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation. 94:1996;3341-3347.